| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 64.379 | 67 |
| GSM780708 | Untreated after 4 days (C2_1) | 59.5473 | 64 |
| GSM780709 | Untreated after 4 days (C3_1) | 61.2603 | 65 |
| GSM780719 | Untreated after 4 days (C1_2) | 67.5239 | 68 |
| GSM780720 | Untreated after 4 days (C2_2) | 65.2536 | 67 |
| GSM780721 | Untreated after 4 days (C3_2) | 65.0769 | 67 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 62.6817 | 66 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 57.4383 | 62 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 64.1996 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 61.9188 | 66 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 57.0591 | 62 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 63.1517 | 66 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 53.745 | 58 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.0363 | 56 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 55.2305 | 60 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.829 | 40 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 68.1333 | 68 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 58.6262 | 63 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 60.2542 | 65 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 61.3975 | 65 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 72.1886 | 70 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 65.747 | 67 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 67.2395 | 68 |